Medicare Enrolled
Dr. Craig Dubois, M.D.
Neurology · Mooresville, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dubois from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dubois?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dubois
Dr. Craig Dubois is a neurology specialist in Mooresville, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dubois performed 18,599 Medicare services across 983 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dubois received a total of $69,200 from 92 pharmaceutical and/or device companies across 1217 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dubois is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in NC
$69,200 industry payments
Medicare Practice Summary
Medicare Utilization ↗18,599
Medicare services
Top 5% in NC for neurology
983
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~930 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Ocrelizumab infusion (Ocrevus) for MS | 17,100 | $42 | $113 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
551 | $81 | $168 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
125 | $69 | $175 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
104 | $48 | $143 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
89 | $16 | $48 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
74 | $133 | $302 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
71 | $54 | $116 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
63 | $20 | $72 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
50 | $92 | $319 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
43 | $8 | $10 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
43 | $4 | $18 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
42 | $61 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
40 | $108 | $245 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
39 | $1 | $18 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
31 | $100 | $321 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
23 | $91 | $290 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
21 | $135 | $422 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
15 | $15 | $73 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
15 | $2 | $22 |
| MRI scan of brain, without contrast A magnetic resonance imaging test of the brain that does not use contrast dye. This procedure creates detailed images of the brain's structure using magnetic fields and radio waves. |
13 | $83 | $860 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
12 | $9 | $54 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
12 | $43 | $111 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
12 | $154 | $511 |
| Nerve conduction study, 3-4 tests A diagnostic test that measures how well nerves send electrical signals. It involves performing 3 to 4 separate nerve conduction studies to evaluate nerve function. |
11 | $86 | $267 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
93.2% high complexity
1.0% medium
5.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$69,200
Total received (2018-2024)
Avg $9,886/year across 7 years
Top 8% in NC for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
92
Companies
1,217
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$52,157 (75.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,043 (24.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,612
2023
$3,004
2022
$11,707
2021
$11,727
2020
$9,063
2019
$7,430
2018
$21,657
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$855
Teva Pharmaceuticals USA, Inc.
$651
TG Therapeutics, Inc.
$338
PFIZER INC.
$254
Neurelis, Inc.
$251
UCB, Inc.
$230
Novartis Pharmaceuticals Corporation
$199
Celgene Corporation
$177
JAZZ PHARMACEUTICALS INC.
$165
Sumitomo Pharma America, Inc.
$154
Biogen, Inc.
$132
Supernus Pharmaceuticals, Inc.
$97
ACADIA Pharmaceuticals Inc
$92
Genentech USA, Inc.
$85
MDD US Operations, LLC
$84
Takeda Pharmaceuticals U.S.A., Inc.
$84
Sandoz Inc.
$79
Neurocrine Biosciences, Inc.
$76
SK Life Science, Inc.
$72
Lilly USA, LLC
$69
Alexion Pharmaceuticals, Inc.
$68
Merz Pharmaceuticals, LLC
$64
ARGENX US, INC.
$61
Kedrion Biopharma, Inc.
$41
Acorda Therapeutics, Inc
$35
Eisai Inc.
$32
SCILEX PHARMACEUTICALS INC.
$24
EMD Serono, Inc.
$24
Azurity Pharmaceuticals, Inc.
$22
Octapharma USA, Inc.
$22
Mallinckrodt Hospital Products Inc.
$21
Lundbeck LLC
$19
Aucta Pharmaceuticals, Inc.
$18
Averitas Pharma Inc.
$17
Top 3 companies account for 40.0% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$19,974
Biohaven Pharmaceuticals, Inc.
$11,978
Supernus Pharmaceuticals, Inc.
$10,143
Biohaven Pharmaceutical Holding Company Ltd.
$9,332
UCB, Inc.
$3,037
Novartis Pharmaceuticals Corporation
$1,081
ABBVIE INC.
$1,049
GENZYME CORPORATION
$948
SK Life Science, Inc.
$858
Biogen, Inc.
$745
Amgen Inc.
$506
ACADIA Pharmaceuticals Inc
$501
Celgene Corporation
$447
Neurocrine Biosciences, Inc.
$417
AbbVie Inc.
$401
US WorldMeds, LLC
$387
PFIZER INC.
$374
Genentech USA, Inc.
$370
Neurelis, Inc.
$367
Avanir Pharmaceuticals, Inc.
$365
TG Therapeutics, Inc.
$338
JAZZ PHARMACEUTICALS INC.
$337
Takeda Pharmaceuticals U.S.A., Inc.
$322
Allergan, Inc.
$311
Lilly USA, LLC
$277
Amneal Pharmaceuticals LLC
$236
Adamas Pharmaceuticals, Inc.
$229
Acorda Therapeutics, Inc
$211
EMD Serono, Inc.
$178
Eisai Inc.
$170
TG THERAPEUTICS, INC.
$169
Lundbeck LLC
$160
Sumitomo Pharma America, Inc.
$154
Alexion Pharmaceuticals, Inc.
$150
Mallinckrodt LLC
$140
MDD US Operations, LLC
$125
ARGENX US, INC.
$119
Inspire Medical Systems, Inc.
$111
Impax Laboratories, Inc.
$109
Merz Pharmaceuticals, LLC
$107
Bausch Health US, LLC
$107
Medtronic, Inc.
$102
Merz North America, Inc.
$95
Greenwich Biosciences, Inc.
$89
LivaNova USA, Inc.
$87
Corium, LLC
$86
Assertio Therapeutics, Inc.
$84
Sandoz Inc.
$79
Grifols USA, LLC
$72
UPSHER-SMITH LABORATORIES LLC
$63
Octapharma USA, Inc.
$55
ARBOR PHARMACEUTICALS, INC.
$51
GE HEALTHCARE
$50
SPR Therapeutics, Inc
$48
SANOFI-AVENTIS U.S. LLC
$46
Bayer HealthCare Pharmaceuticals Inc.
$43
Kedrion Biopharma, Inc.
$41
GE HealthCare
$41
Merck Sharp & Dohme LLC
$38
Mallinckrodt Hospital Products Inc.
$36
Allergan Inc.
$34
Merck Sharp & Dohme Corporation
$33
Boston Scientific Corporation
$33
Vertical Pharmaceuticals, LLC
$33
GRT US Holding, Inc.
$31
IMPEL PHARMACEUTICALS INC.
$31
Philips Electronics North America Corporation
$28
Kyowa Kirin, Inc.
$25
SCILEX PHARMACEUTICALS INC.
$24
EISAI INC.
$24
Azurity Pharmaceuticals, Inc.
$22
E.R. Squibb & Sons, L.L.C.
$21
Collegium Pharmaceutical, Inc.
$18
Aucta Pharmaceuticals, Inc.
$18
Upsher-Smith Laboratories LLC
$18
Forte Bio-Pharma LLC
$18
CSL Behring
$17
Averitas Pharma Inc.
$17
Banner Life Sciences, LLC
$17
Almatica Pharma LLC
$17
Scilex Pharmaceuticals Inc.
$17
Akcea Therapeutics, Inc.
$16
Harmony Biosciences LLC
$16
Janssen Pharmaceuticals, Inc
$16
Arbor Pharmaceuticals, Inc.
$15
Ironshore Pharmaceuticals Inc.
$15
Ipsen Biopharmaceuticals, Inc
$15
Otsuka America Pharmaceutical, Inc.
$14
Zyla Life Sciences
$14
Promius Pharma LLC
$13
Zyla Life Sciences, Inc.
$13
Validus Pharmaceuticals LLC
$12
Top 3 companies account for 60.8% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Albuked · Apokyn · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · COMIRNATY · COPAXONE · Cambia · Cenobamate · Dysport · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Epidiolex · Equetro · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gocovri · Gralise · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INSPIRE · INTELLIS ADAPTIVESTIM · Jornay PM 20mg capsules (Bottle of 100) · KESIMPTA · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NALOCET · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nuedexta · OCREVUS · ONFI · ONZETRA Xsail · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qelbree · Qutenza · RELEXXII · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRINT PNS System · SPRIX · TECFIDERA · TEGSEDI · TOSYMRA · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · WAKIX · WATCHMAN FLX · XADAGO · XCOPRI · XEOMIN · XYWAV · Xadago · Xembify · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zilbrysq · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (75%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for neurology in NC.
Geographic Context
Neurologists within 10 mi
31
Per 100K population
16.2
County median income
$78,678
Nearest hospital
DUKE HEALTH LAKE NORMAN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dubois is a mixed practice specialist, with above-average Medicare volume (top 5% in NC), with speaking/promotional industry engagement in the top 8% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dubois experienced with ocrelizumab infusion (ocrevus) for ms?
Based on Medicare claims data, Dr. Dubois performed 17,100 ocrelizumab infusion (ocrevus) for ms services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dubois receive payments from pharmaceutical companies?
Yes. Dr. Dubois received a total of $69,200 from 92 companies across 1,217 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dubois's costs compare to other neurologists in Mooresville?
Dr. Dubois's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dubois) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Mooresville
Browse neurologists in Mooresville ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NC
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NC
Which NC neurologists receive the most from drug and device companies.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology